nference, Cambridge, United States.
Mayo Clinic, Rochester, United States.
Elife. 2020 Jul 7;9:e58227. doi: 10.7554/eLife.58227.
Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution to guide clinical decision-making. Here, we use deep neural networks over an institution-wide platform for the augmented curation of clinical notes from 77,167 patients subjected to COVID-19 PCR testing. By contrasting Electronic Health Record (EHR)-derived symptoms of COVID-19-positive (COVID; n = 2,317) versus COVID-19-negative (COVID; n = 74,850) patients for the week preceding the PCR testing date, we identify anosmia/dysgeusia (27.1-fold), fever/chills (2.6-fold), respiratory difficulty (2.2-fold), cough (2.2-fold), myalgia/arthralgia (2-fold), and diarrhea (1.4-fold) as significantly amplified in COVID over COVID patients. The combination of cough and fever/chills has 4.2-fold amplification in COVID patients during the week prior to PCR testing, in addition to anosmia/dysgeusia, constitutes the earliest EHR-derived signature of COVID-19. This study introduces an platform for the real-time synthesis of institutional biomedical knowledge. The platform holds tremendous potential for scaling up curation throughput, thus enabling EHR-powered early disease diagnosis.
了解 COVID-19 症状的时间动态可以提供更精细的分辨率,以指导临床决策。在这里,我们使用深度神经网络在全机构平台上对 77167 名接受 COVID-19 PCR 检测的患者的临床记录进行增强整理。通过对比电子健康记录(EHR)中 COVID-19 阳性(COVID;n = 2317)和 COVID-19 阴性(COVID;n = 74850)患者在 PCR 检测日期前一周的 COVID 症状,我们发现嗅觉丧失/味觉障碍(27.1 倍)、发热/寒战(2.6 倍)、呼吸急促(2.2 倍)、咳嗽(2.2 倍)、肌痛/关节痛(2 倍)和腹泻(1.4 倍)在 COVID 患者中显著放大。在 PCR 检测前一周,COVID 患者中咳嗽和发热/寒战的组合放大了 4.2 倍,除嗅觉丧失/味觉障碍外,这构成了 COVID-19 的最早的 EHR 衍生特征。这项研究介绍了一个实时综合机构生物医学知识的平台。该平台具有大幅提高整理效率的巨大潜力,从而能够实现基于 EHR 的早期疾病诊断。